Clinical Trial

Hypoglossal Nerve Stimulation for the Treatment of Adult Obstructive Sleep Apnea

Study acronym: BEAT OSA
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this interventional study is to assess the safety and performance of the XII Medical Hypoglossal Nerve Stimulation (HGNS) System in people who have moderate to severe Obstructive Sleep Apnea (OSA). Participation in this study involves being implanted with a Neurostimulator which provides electrical stimulation of the hypoglossal nerve (HGN). Participants will receive treatment at home during sleep, and participate in sleep studies to track and record the quality of the sleep. Participants will be monitored over the course of the study.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-25; most recent amendment 2025-11-14.
Trial Details
NCT Number NCT07049744
Lead Sponsor XII Medical
Conditions Obstructive Sleep Apnea (OSA)
Enrollment 30 participants
Start Date 2025-06-24
Primary Completion 2026-12 (estimated)
Study Completion 2029-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-30